Sort   by:  
 Page size 
UnknownPopulation pharmacokinetics of ganciclovir after intravenous ganciclovir and oral valganciclovir administration in solid organ transplant patients infected with cytomegalovirus.
Not available
S-EPMC2772326 | biostudies-literature
UnknownSerum ganciclovir drug exposure in children receiving standard ganciclovir dosing.
Not available
S-EPMC11459965 | biostudies-literature
TranscriptomicsUniform, integration-free iPS cells with a safeguard system using human artificial chromosome vectors
Human artificial chromosomes (HACs) have unique characteristics as gene-delivery vector, e.g., episomal transmission and transfer of multiple, large transgenes. Here, we demonstrate the advantages of HAC vectors for reprogramming mouse embryonic fibroblasts (MEFs) to induced pluripotent stem (iPS) c...
ORGANISM(S): Mus musculus 
2011-10-15 | E-GEOD-29441 | biostudies-arrayexpress
ClinicalGanciclovir Plus Arginine Butyrate in Treating Patients With Cancer or Lymphoproliferative Disorders Associated With the Epstein Barr Virus
RATIONALE: The Epstein Barr virus can cause cancer and lymphoproliferative disorders. Ganciclovir is an antiviral drug that acts against the Epstein Barr virus. Arginine butyrate may make virus cells more sensitive to ganciclovir. Combining ganciclovir and arginine butyrate may kill more Epstein Bar...
2005372 | ecrin-mdr-crc
UnknownEarly selection of a new UL97 mutant with a severe defect of ganciclovir phosphorylation after valaciclovir prophylaxis and short-term ganciclovir therapy in a renal transplant recipient.
Not available
S-EPMC1068598 | biostudies-literature
UnknownPreemptive ganciclovir for mechanically ventilated patients with cytomegalovirus reactivation.
Not available
S-EPMC7876264 | biostudies-literature
UnknownRecombinant phenotyping of cytomegalovirus UL97 kinase sequence variants for ganciclovir resistance.
Not available
S-EPMC2876423 | biostudies-literature
UnknownPopulation Pharmacokinetics and Dose Optimization of Ganciclovir in Critically Ill Children.
Not available
S-EPMC7847843 | biostudies-literature
UnknownPharmacokinetics of ganciclovir during continuous venovenous hemodiafiltration in critically ill patients.
Not available
S-EPMC3910760 | biostudies-literature
UnknownAdenoviral-delivered HE4-HSV-tk sensitizes ovarian cancer cells to ganciclovir.
Not available
S-EPMC4440683 | biostudies-literature
Sort   by:  
 Page size